Background Noma is a poorly studied disease that leads to severe facial tissue destruction in children in developing countries, but the cause remains unknown. We aimed to identify the epidemiological and microbiological risk factors associated with noma disease.
Introduction
Noma is a gangrenous disease causing high mortality and devastating facial lesions with severe functional and aesthetic consequences. 1 Hippocrates fi rst described noma in the 5th century BC 2 and the disease continued to be reported throughout Europe until World War 2, when the last reports of noma concerned concentration camp and prison camp inmates. 3, 4 In high-income countries, noma is now extremely rare and aff ects only patients with severe immunosuppression or blood dyscrasia. [5] [6] [7] [8] By contrast, noma still persists in the poorest developing countriesmostly in Africa-and occurs mainly in children younger than 6 years. Cases have also been reported from Latin America and the Asia-Pacifi c region. 9, 10 Although noma cannot be regarded as a major public health problem worldwide, the facial mutilations caused by the disease are intolerable and further research is needed to alleviate the suff ering of aff ected underprivileged populations.
Noma disease develops from a gingival lesion that spreads to the underlying bone. The corresponding facial region develops oedema and becomes necrotic, leading to the destruction of large parts of the soft and hard facial tissues. 1 Findings from observational studies have suggested several possible risk factors for noma disease, including poverty, 11 stunting owing to malnutrition, 12 low birthweight, 13 absence of exclusive breastfeeding, poor sanitation, endemic infections (measles, malaria, and AIDS), poor oral hygiene, and proximity of livestock. [11] [12] [13] Although these factors might have a role in a cascade of events leading to a catastrophic derailment of a disorder that is essentially an opportunistic infection associated with poor health status, the cause of noma remains largely unknown. 1, 11 We aimed to identify risk factors for noma, including epidemiological, biological, microbiological, and sociobehavioural variables.
Methods

Study design and participants
We did a prospective, matched, case-control study of all children diagnosed with acute noma between Aug 1, 2001, and Oct 31, 2006 , in the Zinder region of southeast Niger, a landlocked country in western Africa. Cases were children younger than 12 years who presented with acute necrotising stomatitis with exposure of underlying bone, oedema, or initial facial necrosis (fi gures 1A and B). 1 Controls were children without any signs of noma or acute necrotising gingivitis at study inclusion and matched for age (within 3 months) and home village to cases recruited within 1 month of noma diagnosis. Children with sequelae The study was done in accordance with the Declaration of Helsinki and in collaboration with Sentinelles, a Swiss non-governmental humanitarian organisation. Signed consent (usually by a cross or a fi ngerprint) by the parent or guardian of the child was obtained after oral information was given by local staff in the native language and translated from a French information leafl et. All consent forms were sent to the offi ce of the Geneva Study Group on Noma (GESNOMA) in Geneva, Switzerland. The study was approved by the Ministry of Health of Niger and the WHO noma programme.
Clinical and biological data collection
We did structured interviews with the child's family members at the time of diagnosis for children with noma and at study inclusion for controls, followed by a clinical examination. We recorded demographic, clinical, and nutritional data, including environmental variables, and documented the presence and extent of facial and oral lesions. 14 We did viral sampling by gently rolling a cotton swab tip around the mouth mucosal surface; samples were then stored in dedicated tubes for virus shipment. Microbial samples were taken from the subgingival plaque of teeth with paper points and immersed immediately in guanidinium thiocyanate buff er (RLT-Buff er, Qiagen, Basel, Switzerland). In noma patients, one sample was taken from a diseased site and one from a healthy dentition site. In children presenting with substantial destruction of the gingival tissue with no existing gingival sulcus, the sample was collected at the edge of the lesion. For controls, only one sample was taken from a mandibular anterior tooth.
We took blood samples from both groups. All aliquots of plasma, gingival fl uid, and mucosal swabs were stored at -20°C until shipment and stored on delivery at -80°C at University of Geneva Hospitals. We assessed present (wasting) and past (stunting) nutritional status by anthropometric indicator estimates proposed by WHO and the US Centers for Diseases Control and Prevention (CDC). 15 Scores obtained were calculated and compared with the standard values of the US National Center for Health Statistics.
Biological analyses
We measured plasma concentrations of retinol (vitamin A) and α-tocopherol (vitamin E) with high-performance liquid chromatography (Beckman System Gold, 166 Detector, Beckman Instruments, Fullerton, CA, USA) according to standard techniques. 16 Serology for Epstein-Barr virus used indirect immunofl uorescence assay and quantitative determination of IgM and IgG antibodies against viral capsid antigen in human serum (Abbott AG, Baar/Zug, Switzerland). For herpes simplex virus, varicella zoster virus, cytomegalovirus, and morbillivirus (measles), we used specifi c enzyme immunoassays (Siemens, Marburg, Germany) for the qualitative detection and the quantitative determination of IgM and IgG antibodies. Immunity to measles was defi ned as a positive IgG serology, a record of putative measles vaccination, or a history of disease when serology results were unavailable. Mucosal swabs were inoculated on human fi broblasts (primary culture strains) and three continuous cell lines (A549, Vero, and MDCK) to detect the possible presence of viruses. In a second step, cytomegalovirus early antigen from saliva and mucosal swabs was assessed with shell vial cell culture technique and by staining with monoclonal antibodies (Argene, Varilhes, France).
Microbiological procedures and microarrays
We extracted total genomic DNA with glass beads (diameter 212-300 μm; Sigma-Aldrich, Buchs, Switzerland) and a DNeasy kit (Qiagen), according to the manufacturer's instructions. We undertook asymmetrical PCR with biotinylated universal primers fD1 (0·4 μM) and rD1 (4 μM) as described previously. 17 We used spectrophotometry (NanoDrop ND-1000 Spectrophotometer, NanoDrop On the basis of the most relevant sequences identifi ed in a previous pilot investigation, 18 to a set of 271 probes. Additionally, we included probes specifi c to various Archaebacteria and eight negative control probes, resulting in a fi nal set of 335 probes. Oligonucleotide probes were synthesised with a C6-linker with free primary amine and spotted on ArrayStrip microarrays (Clondiag GmbH, Jena, Germany). We processed microarrays with proprietary reagents according to the manufacturer's instructions. We established signal intensities with IconoClust software (Clondiag GmbH). For every spot, the extinction signal of local background was subtracted from the intensity value. Array signals were fi rst adjusted to normalise the DNA quantity. Each array was then normalised against the eight negative control probes and subjected to quantile normalisation with the Partek Genomic Suite 6.4.
Statistical analysis
The sample size was calculated to detect a 2·5-fold increase in the odds of development of noma in the presence of one specifi c predictor with 5% signifi cance and 80% power. The calculation showed that 80 cases, each with four matched controls, would be necessary to show such an association. 19 We assumed that the main risk factor would be present in 60% of controls and that the correlation coeffi cient for exposure between matched cases and controls would be 0·45.
To assess independent risk factors, we included all variables associated with an increased likelihood of noma in univariate analysis at a signifi cance level of a p=0·25 in a multivariate, conditional logistic regression model with a forward stepwise procedure. We estimated the percentage of variance in the outcome explained by the model by calculation of a pseudo-R² value.
Microarray data were also analysed by conditional logistic regression. We compared diseased with healthy sites in cases, healthy sites in cases with controls, and diseased sites in cases with controls. We corrected for multiple testing with the false discovery rate method; 20 all p values less than 0·0238 were regarded as signifi cant. The 132 phylotypes with signifi cant p values led to 396 conditional logistic regression models. Bacterial genera that were signifi cantly associated with case-control status at conditional logistic regression were analysed and tested for log linearity. Since log linearity was not respected, we used categorical variables, based on the quintiles of their distribution for each bacteria. Variables retained in the two previous steps were included in the fi nal conditional logistic regression model. Because of the low number of events per variable, 21 we presented a parsimonious model including only signifi cant variables associated with the case status plus age that was kept in the model. All clinical and epidemiological variables and microbiological data from the healthy site of noma cases signifi cantly associated with noma status were kept in the fi nal model. All tests were two-tailed and p values less than 0·05 were regarded as signifi cant. We used Stata (version intercooled 12.0) for all analyses. Data are mean (SD) or number (%). *Provided by conditional logistic regression. †Comparison between history of malaria in the past 3 months and no crisis or malaria more than 3 months before noma. 
Cases
Role of the funding source
The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication.
Results
We recruited 85 noma cases and 327 controls. Three cases were excluded for administrative reasons, resulting in 82 eligible cases. For one case, only three controls were matched. Overall, seven deaths (8·5%) were attributable to noma; one other child died 1 year after noma diagnosis because of malaria complications. All children received adequate antibiotics (amoxicillin plus metronidazole) immediately after diagnosis and biological specimen sampling. Figure 2 shows the epidemic curve of new noma cases during the study period. Cases were identifi ed from all areas of the Zinder region (fi gure 3). Table 1 shows the baseline characteristics of the study population. Most cases were recruited at the Sentinelles centre for noma care after referral from a dispensary (n=28, 34·1%) or a hospital (n=22, 26·8%), or were brought in by their family (n=26, 31·7%). Six (7·3%) cases were identifi ed in remote villages during follow-up visits to children who had previously been operated on. Mean delay to consultation at the centre was 8·1 days (SD 12·6; median 3 days, range 0-50). 20 patients (24·4%) had already received antibiotics for more than 24 h, and 33 (40·2%) had been exposed to traditional medicine procedures before seeking medical attention. At clinical presentation, 24 cases (29·3%) had a body temperature of 38·5°C or higher, 73 (89·0%) enlarged submandibular lymph nodes, six (7·3%) general oedema, and fi ve (6·1%) ascites. Locally, cases presented with facial oedema (n=45, 54·9%) or initial necrosis (n=38, 46·3%), with external (n=22, 26·8%) or buccal (n=68, 82·9%) bone exposure, or both. 75 cases (91·5%) had local pain. At oral assessment, 77 cases (93·9%) presented with halitosis and 61 (75·4%) with pseudomembranes. 68 (82·9%) showed signs of gingivitis, including 45 (54·9%) with spontaneous gingival bleeding. 60 cases (73·1%) showed loss of tips of interdental gingival papilla and 35 (42·7%) presented with other oral lesions. Table 2 shows a comparison of the nutritional habits and environmental life conditions between cases and controls.
Because of poor health conditions and dehydration, blood samples from only 20 cases (24·4%) and 114 controls (34·9%) were available for measurement of vitamin concentrations (table 3) . We recorded very low serum concentrations of vitamins A and E (<1 μmol/L) in both groups. Antiviral antibody concentrations for diff erent viruses could be measured in samples for 61-69 cases (74·4-84·1%) and 239-317 controls (73·1-96·9%; table 3). We recorded no signifi cant diff erence between cases and controls in terms of recent or past immunisation against measles (IgG positivity <65% in both groups) or other viral diseases (table 3) . Mucosal swab testing did not identify notable acute viral illness in cases or controls (table 3) .
On the basis of complete clinical epidemiological data available for 407 children (table 4) , severe wasting and stunting, a high number of past pregnancies in the mother, the presence of febrile illness in the past 3 months, and the absence of chickens at home were signifi cant risk factors for noma disease. The proportion of variance explained by the model was 27%.
After exclusion of 20 cases who received antibiotics or whose specimens deteriorated, we processed 117 microbial samples from noma cases (59 from diseased sites and 58 from healthy sites) and 235 from controls. Each specimen yielded a maximum of 132 diff erent results corresponding to the number of phylotypes sought by low-density 16s rDNA array. 22 Of 396 comparisons, 185 (46·7%) provided signifi cant diff erences with use of the predetermined false discovery rate cutoff . We used data from the healthy sites of cases and obtained complete data for 291 observations (59 cases and 232 controls), which were similar in all characteristics to the original dataset of 409 children (82 cases and 327 controls; data not shown). By multivariate analysis, we identifi ed fi ve bacterial genera that were signifi cantly associated with case status compared with controls: Capnocytophaga, Fusobacterium, Neisseria, Prevotella, and Spirochaeta (table 5). When we introduced microbiological variables into the clinicoepidemiological model (table 6) , severe stunting and a higher number of past pregnancies in the mother were independently associated with noma, together with microbiological predictors of disease: a reduced proportion of Spirochaeta, Fusobacterium, Capnocytophaga, and Neisseria in the oral microbiota, but an increased proportion of Prevotella. The proportion of variance explained by the model was 42%. 
Discussion
Our fi ndings provide new insight into the understanding of the risk factors for noma disease and take into account sociodemographic, clinical, biological, and microbiological factors that are potentially involved in its pathogenesis (panel). 1, 11, 23 Disease predictors include severe malnutrition, recent respiratory or diarrhoeal syndrome, the number of previous pregnancies in the mother, the absence of chickens at home, and an altered oral microbiota compared with controls.
Malnutrition was very apparent in our study population. Importantly, both present and past malnutrition was a risk factor for noma. 24 By comparing each case to four matched controls, we showed that aff ected children were more undernourished than were controls. In Niger, chickens are a sign of wealth and their absence in the case environment and the presence of a higher number of people in the household are surrogate indicators of poverty that might explain the degree of acute and chronic malnutrition of these children. Investigators of some studies 13, 25 have reported that noma could be related to a higher number of previous pregnancies in the mother. In sub-Saharan Africa, pregnant and lactating women are especially at risk of maternal malnutrition related to poor nutritional quality and short interpregnancy intervals. 26 Frequent pregnancies often cause maternal anaemia, resulting in an increased risk of low-birthweight babies. 11, 13 Debilitating diseases, especially malaria and measles, have been described as possible contributory factors for noma. 4, 24 We noted that the risk of noma increased in the presence of a recent febrile respiratory or digestive illness, which again suggests that aff ected children had a worse health status than did controls. Measles could be one of the most important risk factors for noma because of the accompanying immunosuppression. 24, 25 Our data showed that immunity against measles, either through vaccination or previous disease, was insuffi cient in the overall study population, and exposure to measles was not associated with an increased risk of disease. Herpes viruses, particularly cytomegalovirus or Epstein-Barr virus, could trigger the evolution of a pre-existing gingivitis towards acute necrotising gingivitis and noma. 11, 12, 27 Although we tested for the presence of herpes in mucosal swabs, our results seemed to exclude this hypothesis, but we could not exclude a type 2 error or the existence of a viral pathway that we did not explore in our study.
In addition to the many epidemiological facets of the disease, noma has always been regarded as a disease of bacterial origin because of the smell of the lesion, its rapid evolution, and possible response to broad-spectrum antibiotic treatment. 1, 11, 12, 28 Apart from fi ndings from early studies 29, 30 that reported the presence of spirochaetes and fusiform organisms via dark fi eld microscopy, recent eff orts to prove a primary microbiological cause have been unsuccessful because of diffi culties in accessing and assessing acute cases 31 and the unavailability of modern laboratory techniques in the countries where noma is present. Microbiota associated with noma lesions were studied in a few patients with anaerobic culturing techniques. 32 Microorganisms identifi ed as Fusobacterium necrophorum and Prevotella intermedia on the basis of phenotypic criteria were recovered from seven and six of the eight sampled noma lesions, respectively. In our study, we used advanced molecular techniques and included only acute noma cases to investigate potential causative microorganisms. Microarrays off er the dual advantage of assessment of the possible presence of a We noted signifi cant independent associations between noma and microbiological species, including a trend towards an increased risk of disease when the Fusobacterium genus was under-represented. F necrophorum, a commensal found in the gut of herbivores and a cause of necrotising infections in animals, might contaminate livestock and potentially infect children. 11, 32 F necrophorum was found in seven of eight advanced noma lesions in a previous report 31 and has long been regarded as one of the putative pathogens of noma. 31, 32 However, the ten phylotypes of Fusobacterium genus recorded in our study belong to the Fusobacterium nucleatum complex (data not shown). Other representatives of the Fusobacteriales family tended to be associated with healthy sites. Thus, the intriguing hypothesis that F necrophorum could act as a trigger organism was not confi rmed in our study with molecular techniques. Rather, we noted an alteration of the oral microbiota of noma cases, with a reduced amount of Fusobacterium genus. By contrast, P intermedia, a pathogen identifi ed frequently in adult periodontitis, 32 was clearly associated with noma. In previous studies, investigators have reported its presence and its putative role in noma lesions; 11, 32, 33 it might play a part by promoting tissue destruction through lipid and protein degradation. 31 P intermedia produces IgA1 proteases that could be crucial in changing mouth mucosal immunity, 34, 35 but this species is not recognised as a mono-infecting agent. 36, 37 Noma cases also had a lower proportion of Capnocytophaga spp, Neisseria spp, and Spirochaeta spp than did controls. In a study in which investigators compared the microbial composition of supragingival and subgingival plaque of patients with periodontitis, supragingival samples had statistically signifi cantly higher counts of Neisseria mucosa, Capnocytophaga ochracea, and Capnocytophaga sputigena than did the subgingival samples, whereas subgingival samples, taken from the same teeth, had statistically signifi cantly higher counts of Prevotella nigrescens and P intermedia than did supragingival samples. 38 This diff erence might represent an imbalance in the microbiota, with a composition more closely related to the subgingival microbiota in periodontal diseases that promotes the overgrowth of opportunistic pathogens. Importantly, we did not identify any specifi c causative pathogen for noma disease with low-density microarrays. However, for technical reasons and density issues, the microarray analysis is dedicated only to bacteria and some Archaea, but did not detect fungi or parasites. Of note, neither fungi nor parasites have been suspected in the pathogenesis of noma disease. 1, 11 Our study has some limitations. First, we did not strictly respect age matching between cases and controls (ie, we attempted to match controls to their cases in terms of age, but globally we found that matched controls were signifi cantly older than cases) 
Panel: Research in context
Systematic review
We searched PubMed and Medline for papers published in French and English between Jan 1, 1969 and Oct 1, 2012, with the terms "noma", "cancrum oris", "acute necrotizing gingivitis/acute necrotizing ulcerative gingivitis and noma", "acute necrotizing gingivitis/ acute necrotizing ulcerative gingivitis and malnutrition", "acute necrotizing gingivitis/ acute necrotizing ulcerative gingivitis and herpes viruses/herpesviridae", and "Fusobacterium necrophorum". We also searched the reference lists of identifi ed articles for further relevant papers and the personal libraries of the authors (DB-M, BP-C, AM, DM, JS, and DP). Previous studies of risk factors for noma reported the importance of malnutrition and debilitating diseases, such as malaria or measles. However, no investigators have done a case-control study that includes only acute cases and control children from the same region and at the same time. Moreover, none of the previous studies presented a formal sample size estimation, which suggests that these studies might have had inadequate power to detect a specifi c association with some bacteria or other risk factors. Of note, early studies suggested that bacteria had a crucial role in noma pathogenesis, but most had a small sample size and included patients with non-acute noma. Finally, previous analyses used only microscopy and culture techniques that were standard at the time of the study.
Interpretation
To the best of our knowledge, this study is the fi rst to assess both epidemiological risk factors and microbiology with a case-control design. From a practical perspective, our data confi rm the importance of pre-existing malnutrition and the role of poverty in children with noma. Our results showed no involvement of specifi c bacteria in the cause of the disease. Overall, these data suggest new areas of research and draw attention to potential new primary preventive strategies to be developed for the disease.
but we adjusted for this problem in all multivariate models. Second, we attempted blood and other biological sampling only once, but it was impossible in some cases because of children's poor health status and a high occurrence of dehydration. We excluded 28% of observations in the global model because of missing data for microbiological variables. However, a comparison of the total study population with the subset of 291 children without any missing data showed that they shared similar characteristics (data not shown), which strongly suggests the absence of selection bias. Third, the inherent bias common to all case-control studies (mainly recall bias, retrospective design, and temporality, because risk factors were assessed after the development of noma) is certainly present in our study, especially in the assessment of nutritional habits and environmental life factors. However, noma is a rare disease and the case-control approach used was the most appropriate design to study such a disorder.
We are confi dent that these fi ndings could be extrapolated to a larger population of children in Niger and surrounding countries. In terms of sociodemographic and clinical characteristics, our study population was representative of children with noma in sub-Saharan Africa. Cases were managed according to WHO recommendations, thus making our fi ndings gener alisable to the overall at-risk population.
This study does not provide evidence for the existence of one bacterial pathogen as a cause for the disease, including previous suspects, but the results do strongly suggest that an altered oral microbiota increases the risk of disease, independent of sociodemographic and environmental factors. Our fi ndings show that the eradication of noma disease needs concerted eff orts to alleviate poverty, promote improved nutrition of both pregnant women and infants, and help to teach parents to recognise early signs of the disease. The 2012 report on the progress of the UN Millennium Development Goals emphasises that the target of reducing extreme poverty has been reached 5 years ahead of the 2015 deadline in Niger. 39 Despite this achievement, an urgent need remains to associate health campaigns aimed at improving oral care with existing successful strategies against malnutrition in sub-Saharan countries where noma is especially prevalent. 1, 9, 11 Contributors DB-M, AG-A, SH, and DP had responsibility for the overall study design, management, conduct, analysis, and writing of the paper. DB-M, AG-A, SH, and DP were involved in the interpretation, synthesis, and writing of the paper. DB-M, BP-C, DM, AG, J-EB, and DP were involved in the fi eld visits and site study monitoring. PF, AH, and JS were responsible for the development of microbiological techniques. DBM, AM, PF, AH, JS, AG-A, and DP contributed to the data analysis and interpretation, and writing. The Geneva Study Group on Noma conceived and organised the study and provided a forum for discussion throughout the analysis. All authors reviewed and approved the fi nal version.
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